Avalo Therapeutics, Inc. Common Stock
AVTX
AVTX: Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.
moreShow AVTX Financials
Recent trades of AVTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AVTX's directors and management
Government lobbying spending instances
-
$30,000 Apr 19, 2023 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 18, 2023 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Oct 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jul 18, 2022 Issue: Medical/Disease Research/Clinical Labs
New patents grants
Federal grants, loans, and purchases
Followers on AVTX's company Twitter account
Number of mentions of AVTX in WallStreetBets Daily Discussion
Recent insights relating to AVTX
Recent picks made for AVTX stock on CNBC
ETFs with the largest estimated holdings in AVTX
Flights by private jets registered to AVTX